TY  -  JOUR
AU  -  Masseroli, Matteo Maria
AU  -  Meschia, Alessia
AU  -  Ceriani, Elisa
AU  -  Cogliati, Chiara Beatrice
AU  -  Brucato, Antonio Luca
AU  -  Di Mattia, Daniel
T1  -  IL-1 inhibition in highly inflammatory recurrent pericarditis with exercise-associated relapse and cardiac tamponade in a young athlete: a case report
PY  -  2026
Y1  -  2026-07-01
DO  -  10.1728/4812.48404
JO  -  Medicina dello Sport
JA  -  Med Sport
VL  -  79
IS  -  3
SP  -  174
EP  -  179
PB  -  Il Pensiero Scientifico Editore
SN  -  1827-1863
Y2  -  2026/11/19
UR  -  http://dx.doi.org/10.1728/4812.48404
N2  -  Summary. Recurrent pericarditis represents a clinical challenge in athletes, particularly when decisions regarding physical activity resumption remain poorly standardized. We report the case of a 26-year-old male track-and-field athlete with inflammatory recurrent pericarditis. He presented with chest pain, fever, and elevated C-reactive protein. Despite an initially favorable clinical course with standard therapy including indomethacin and colchicine, he developed a first recurrence after treatment tapering, two months after the initial presentation. Corticosteroids were added, with initial clinical benefit. Despite ongoing full-dose anti-inflammatory and corticosteroid therapy and in the absence of treatment tapering, he experienced a second recurrence approximately two weeks later, shortly after a single session of mild physical exercise; this was complicated by cardiac tamponade requiring urgent pericardiocentesis (600 ml). The introduction of anakinra, an IL-1 receptor antagonist, led to rapid improvement and supported progressive simplification of other treatments over the following weeks. After a few months of remission, under ongoing anakinra treatment, the patient resumed mild physical activity; after one year, he returned to intense physical exercise without relapse. This case underscores the importance of early recognition of the highly inflammatory phenotype, the role of IL-1 inhibition in selected patients, and the need for an individualized return-to-play strategy in competitive athletes.
ER  -   
